Relapsing Forms of Multiple Sclerosis
Neurology·MeSH: Multiple Sclerosis
22 drugs in development·15 companies·2 clinical trials
Drug Pipeline by Phase
Approved(17)
Phase 3(3)
Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Relapsing Forms of Multiple Sclerosis?
BioSniper tracks 22 drugs in development for Relapsing Forms of Multiple Sclerosis across 15 companies.
How many clinical trials target Relapsing Forms of Multiple Sclerosis?
There are 2 clinical trials targeting Relapsing Forms of Multiple Sclerosis tracked by BioSniper.
Deep-dive into Relapsing Forms of Multiple Sclerosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis